Hostname: page-component-6898cfcb55-zkb6p Total loading time: 0 Render date: 2026-11-11T23:19:22.296Z Has data issue: false hasContentIssue false
  • English
  • Français

Antimicrobial utilization data: Does point prevalence data correlate with defined daily doses?

Published online by Cambridge University Press:  11 June 2019

Stephen B. LeeOpen the ORCID record for Stephen B. Lee[Opens in a new window],
Daniel J.G. Thirion,
Neal Irfan,
Melani Sung,
Annie Brooks,
Fatimah Al-Mutawa,
Charles Frenette and
Dominik MertzOpen the ORCID record for Dominik Mertz[Opens in a new window]
Stephen B. Lee
Affiliation:
McMaster University, Hamilton, Ontario, Canada
Daniel J.G. Thirion
Affiliation:
Université de Montréal, Montréal, Quebec, CanadaMcGill University, Montreal, Quebec, Canada
Neal Irfan
Affiliation:
Hamilton Health Sciences, Hamilton, Ontario, Canada
Melani Sung
Affiliation:
McMaster University, Hamilton, Ontario, CanadaHamilton Health Sciences, Hamilton, Ontario, Canada
Annie Brooks
Affiliation:
McMaster University, Hamilton, Ontario, CanadaHamilton Health Sciences, Hamilton, Ontario, Canada
Fatimah Al-Mutawa
Affiliation:
McMaster University, Hamilton, Ontario, Canada
Charles Frenette
Affiliation:
McGill University, Montreal, Quebec, Canada
Dominik Mertz*
Affiliation:
McMaster University, Hamilton, Ontario, CanadaHamilton Health Sciences, Hamilton, Ontario, Canada
*
Author for correspondence: Dominik Mertz, Email: mertzd@mcmaster.ca
Rights & Permissions [Opens in a new window]

Abstract

We correlated antibiotic consumption measured by point prevalence survey with defined daily doses (DDD) across multiple hospitals. Point prevalence survey had a higher correlation (1) with monthly DDDs than annual DDDs, (2) in nonsurgical versus surgical wards, and (3) on high- versus low-utilization wards. Findings may be hospital specific due to hospital differences.

Information

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 40 , Issue 8 , August 2019, pp. 920 - 921
Copyright
© 2019 by The Society for Healthcare Epidemiology of America. All rights reserved. 

Antimicrobial resistance and the slow development of new drugs is a significant problem, making effective antimicrobial stewardship programs a priority.Reference Barlam, Cosgrove and Abbo1 Antibiotic utilization is a key quantitative metric of stewardship. In particular, days of therapy (DOT) and daily defined dose (DDD) are commonly accepted and used metrics.Reference Morris2 Point prevalence survey (PPS) of antibiotic use is a relatively short but resource-intensive metric used for cross-facility comparisonReference Aghdassi, Gastmeier and Piening3 in worldwide projects such as the Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (Global PPS).4 To the best of our knowledge, no study has compared PPS to the well-accepted DDD or DOT in acute-care hospitals. Hence, we aimed to assess the correlation between PPS and DDD.

Methods

In this study, 5 hospitals with a total of 48 wards conducted a Global PPS in 2017: 2 tertiary-care hospitals in Hamilton, Ontario (May 17 and August 1, 2017, respectively), and 3 hospitals in Montreal, Quebec (June 6, 2017).4 We included a wide range of services such as medicine, surgery, intensive care, bone marrow transplantation, and solid organ transplantation. Emergency room and pediatric units were excluded.

Global PPS entails collection of data on a given day for all hospitalized patients on systemic anti-infectives: antifungal, antiviral, and antibacterial with the exception of nystatin and sulfasalazine. We calculated the point prevalence by dividing the number of patients on any anti-infective by the number of patients on a specific ward. The proportion calculated can be >1.0 if the average patient received >1 anti-infective. Dispensed antibiotics in DDD per 1,000 patient days were routinely collected at all sites using standard definitions and analyzed in monthly and annual groups.5

Using the 48 wards as the unit of observation and with Pearson’s correlation (Microsoft Excel 2016, Redmond, WA), we assessed the association between the proportion of patients on antibiotics on the day of the PPS and the DDD per 1,000 patient days in the corresponding month of the PPS as well as the DDDs for the entire calendar year.6 Finally, we conducted exploratory subgroup analyses based on hospital site, and type of ward. We grouped the wards into the bottom third, middle third, and highest third of utilization based on DDDs hypothesizing that wards with higher utilization have a stronger correlation due to less relative variance.

Results

Of 1,228 patients, 473 (39%) were on systemic anti-infectives across all sites (n = 138, 46%): 111 (33%) at the Hamilton sites, and 17 (27%), and 145 (44%) and 62 (35%) at the Montreal sites, respectively. The proportion of patients on anti-infectives by ward ranged from 0 to 100%. The DDD per 1,000 patient days ranged from 94.8 to 1,699.1 for the corresponding month of the PPS and from 160.6 to 1,700.8 for the annual consumption.

The correlation coefficient (R) comparing PPS to the DDD per 1,000 patient days in the month of the PPS was 0.62 (Fig. 1a). The correlation coefficient was lower (R = 0.56) than the DDD per 1,000 patient days in the calendar year of the PPS (Fig. 1b). Most outliers were surgical units. When separated into surgical and medical units, nonsurgical units correlated with an R of 0.63 for monthly and 0.57 for annual DDD, respectively, whereas surgical units had Rs of 0.57 and 0.52, respectively. The most extreme outliers were in Montreal: When surgical units were excluded at the 3 Montreal sites, the correlation coefficient was 0.29. At one of the Montreal hospitals, a surgical unit closed and surgical patients had been offloaded onto a medical unit, which likely explains this low R value. When we excluded this unit, the correlation coefficient increased to R = 0.57. The largest correlation coefficient was found at Hamilton sites in nonsurgical wards (R = 0.79). The volume of anti-infective use had a gradual effect on the correlation coefficient: Rs were 0.54 annually and 0.65 monthly for the highest-usage wards; 0.40 annually and 0.48 monthly for the intermediate-usage wards; and 0.32 annually and 0.36 monthly for the lowest-usage group.

Fig. 1.

(a) Overall correlation between point prevalence and defined daily doses per 1,000 patient days in the month of the point prevalence survey. (b) Overall correlation between point prevalence and defined daily doses per 1,000 patient days in the calendar year of the point prevalence survey.

Discussion

Our study assessed the correlation between point prevalence and annual and monthly DDD per 1,000 patient days across 5 centers in 2 Canadian cities. The correlation with DDD per 1,000 patient days of the month of the PPS was stronger than the correlation between PPS and the annual DDD per 1,000 patient days. Surgical units and units with lower antibiotic utilization also showed weaker correlations.

In every analysis performed, point prevalence was more closely correlated to monthly DDD per 1,000 patient days than if compared to the annual average utilization. This highlights the variation in antibiotic utilization over 1 year, influenced by changes in patient population and seasonal trends. During the winter, a high rate of respiratory illnesses generally occurs,Reference Moineddin, Nie, Domb, Leong and Upshur7 and the volume of elective surgeries declines during summer,Reference Caillet, Payet, Polazzi, Carty, Lifante and Duclos8 both potentially resulting in seasonal variation in anti-infective use. Thus, PPS data from one season may not be comparable to PPS data from another facility during a different season. Also, physician practice may also influence usage; such factors include not only the accumulation of experience (eg, newly graduated and postgraduate physicians starting in July) but also physician turnover with different practices.Reference Fakih, Hilu, Savoy-Moore and Saravolatz9

Finally, surgical prophylaxis may vary from day to day based on surgical volume variation, which does not affect antibiotic utilization on nonsurgical wards. These factors can explain the more pronounced variation in surgical units and the higher correlation for nonsurgical versus surgical wards. Low-utilization units appear to be more prone to variation, which is illustrated by a gradient increase in the correlation coefficient from low-, to intermediate-, to high-utilization units.

Although these trends in correlation coefficient differences held true at all sites; we observed a difference in the level of correlation between Hamilton and Montreal. The higher volume of surgical patients in Montreal may explain the lower correlation coefficient at these sites. Thus, correlation may be site specific, probably driven by the aforementioned factors, which result in more variation in anti-infective use depending on patient population. Hence, the main limitation of our study is that the findings are not necessarily generalizable to any settings. However, our findings are consistent with another similar study we are aware of, which showed a correlation in nursing homes between DOT and weekly PPS. In our study, the latter was less prone to seasonal variation than a single PPS.Reference Barney, Felsen and Dumyati10

Our data suggest that correlation between PPS and DDD per 1,000 patient days (1) is affected by seasonal variation in anti-infective use, (2) is stronger on nonsurgical units, and (3) can vary by site. These findings are important when interpreting the data and when using PPS data for interfacility comparison. Larger-scale studies are needed.

Author ORCIDs

Stephen Lee 0000-0002-6253-293X; Dominik Mertz 0000-0003-4337-1613

Acknowledgments

The authors would like to thank Fahad Aldhufairi for assistance with data collection.

Financial support

No financial support was provided relevant to this article.

Conflicts of interest

All authors report no conflicts of interest relevant to this article.

References

Barlam, TF, Cosgrove, SE, Abbo, LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016;62:e51–e77.CrossRefGoogle Scholar
Morris, AM. Antimicrobial stewardship programs: appropriate measures and metrics to study their impact. Curr Treat Options Infect Dis 2014;6:101–112.CrossRefGoogle ScholarPubMed
Aghdassi, SJS, Gastmeier, P, Piening, BC, et al. Antimicrobial usage in German acute care hospitals: results of the third national point prevalence survey and comparison with previous national point prevalence surveys. J Antimicrob Chemother 2018;73:1077–1083.CrossRefGoogle ScholarPubMed
Global Point Prevalence Study (Global-PPS) website. http://www.global-pps.com/. Updated 2019. Accessed February 12, 2019.Google Scholar
World Health Organization. Essential Medicines and Health Products. Defined Daily Doses. Global Point Prevalence Study website. http://www.global-pps.com/. Updated 2019. Accessed February 12, 2019.Google Scholar
Correlation and Regression. British Medical Journal website. https://www.bmj.com/about-bmj/resources-readers/publications/statistics-square-one/11-correlation-and-regression. Accessed April 18, 2019.Google Scholar
Moineddin, R, Nie, JX, Domb, G, Leong, AM, Upshur, RE. Seasonality of primary care utilization for respiratory diseases in Ontario: a time-series analysis. BMC Health Serv Res 2008;8:160.CrossRefGoogle ScholarPubMed
Caillet, P, Payet, C, Polazzi, S, Carty, MJ, Lifante, JC, Duclos, A. Increased mortality for elective surgery during summer vacation: a longitudinal analysis of nationwide data. PLoS One 2015;10:e0137754.CrossRefGoogle ScholarPubMed
Fakih, MG, Hilu, RC, Savoy-Moore, RT, Saravolatz, LD. Do resident physicians use antibiotics appropriately in treating upper respiratory infections? A survey of 11 programs. Clin Infect Dis 2003;37:853–856.CrossRefGoogle ScholarPubMed
Barney, GR, Felsen, CB, Dumyati, GK. One-day point prevalence as a method for estimating antibiotic use in nursing homes. Infect Control Hosp Epidemiol 2019;40:221–223.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1.(a) Overall correlation between point prevalence and defined daily doses per 1,000 patient days in the month of the point prevalence survey. (b) Overall correlation between point prevalence and defined daily doses per 1,000 patient days in the calendar year of the point prevalence survey.